angiotensin receptor blocker


Also found in: Medical, Acronyms.

angiotensin receptor blocker

n
any of a class of drugs that block the uptake of angiotensin: used in the treatment of high blood pressure
References in periodicals archive ?
ATLANTA--The combined use of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker was associated with an increased risk of hyperkalemia and acute kidney injury in patients with diabetic nephropathy in a randomized, controlled trial that was halted early because of these safety concerns.
Part of that grant includes a study in which half of 140 young adult sodium retainers take an angiotensin receptor blocker for about a week while the remainder take a placebo.
An angiotensin receptor blocker, which prevents the hormone angiotensin from raising blood pressure, increased blood flow during exercise.
Two of Tribenzor s ingredients, olmesartan medoxomil and amlodipine, are an angiotensin receptor blocker and a calcium channel blocker, respectively, sold by Daiichi Sankyo as Benicar and by Pfizer as Norvasc.
Summary: TWYNSTAEeA, the combination of telmisartan (the only angiotensin receptor blocker (ARB) with a broad cardiovascular protection indication) and amlodipine, provides effective and consistent blood pressure (BP) reduction throughout 24 hours.
Summary: For NON-US Medical Media Only Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide.
Avoid prescribing an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) for patients at high risk of vascular events or renal dysfunction.
Food and Drug Administration (FDA) for a fixed dose combination of two antihypertensives, the calcium channel blocker (CCB) amlodipine besylate (currently marketed by Pfizer as Norvasc) and the angiotensin receptor blocker (ARB) olmesartan medoxomil, or Benicar.
A third possibility is to try a drug with longer action than the lisinopril, like olmesartan, which is an angiotensin receptor blocker.
Exforge utilizes two complementary mechanisms of action through the calcium channel blocker (CCB) amlodipine and the angiotensin receptor blocker (ARB) valsartan.
The two trials will compare standard therapy using an angiotensin-converting enzyme inhibitor (ACE-inhibitor) to intensive therapy using both an ACE-inhibitor and an angiotensin receptor blocker (ARB).

Full browser ?